Develops next-generation targeted drugs for human diseases using innovative discovery platforms and a science-driven R&D approach.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Allorion Therapeutics is a biotechnology company focused on developing next-generation targeted drugs for human diseases by leveraging innovative discovery platforms and a science-driven R&D strategy. The company aims to address unmet patient needs and advance commercialization through partnerships with leading pharmaceutical companies.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Investors
Elikon Venture
Firstred Capital
IDG Capital Partners
Med-Fine Capital
Octagon Capital
Qiming Venture Partners
TF Capital
Allorion Therapeutics Valuations & Financials
View real-time NPM data on Allorion Therapeutics stock including daily Allorion Therapeutics stock price estimates, valuation history, and historical share price information. Access Allorion Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Allorion Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Allorion Therapeutics? Get in touch to learn more.
Similar Companies
like Allorion Therapeutics
ParaGen Technologies
Healthcare & Life Sciences
Provides specialty semiconductor materials that enable precision chip fabrication and enhanced device performance.
WriteWise
Healthcare & Life Sciences
Enabling employers to manage pharmacy benefits by transforming claims data into actionable insights for cost savings.
Synapticure
Healthcare & Life Sciences
Delivers care which supports patients with neurodegenerative illnesses through virtual access to treatment, monitoring, and coordination.
Epic Sciences
Healthcare & Life Sciences
Provides diagnostic insights into cancer by analyzing circulating tumor cells and related biomarkers for precision therapy.
Cresilon
Healthcare & Life Sciences
Develops plant-based hemostatic gels for rapid bleeding control in veterinary and human care.
TRIO Pharmaceuticals
Healthcare & Life Sciences
Develops bispecific antibodies that target cancer cells and immunosuppressor cells simultaneously, creating dual-action tumor treatments.
Gilgamesh Pharma
Healthcare & Life Sciences
Develops rapid-acting experimental therapies targeting psychiatric and neurological disorders with novel chemical entities.
Ollin Biosciences
Healthcare & Life Sciences
Develops antibody therapies targeting multiple disease pathways to improve treatment efficacy in ophthalmic diseases.
Dash Bio
Healthcare & Life Sciences
Accelerates clinical bioanalysis that integrates AI‑driven robotics and software to deliver fast, high‑quality assays for drug development.
FAQ
We have answers
Allorion Therapeutics stock does not trade on public stock exchanges. Allorion Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Allorion Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Allorion Therapeutics Stock does not trade on public stock exchanges. In order to sell Allorion Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Allorion Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Allorion Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Allorion Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Allorion Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Allorion Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Allorion Therapeutics is a private company and has not had an IPO. There is currently no Allorion Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Allorion Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
